Association of the ANCA Kidney Risk Score With Kidney Failure in Anti-Glomerular Basement Membrane Disease.
文献摘要
Introduction Anti-glomerular basement membrane (anti-GBM) disease is a rare vasculitis that is characterized by a poor renal prognosis. Despite the high predictive accuracy of the improved antineutrophil cytoplasmic autoantibody (ANCA) Kidney Risk Score (AKRiS) in ANCA-associated vasculitis, its prognostic value in anti-GBM disease remains to be established. Methods In this multicenter retrospective study, 163 biopsy-proven patients with anti-GBM were included. AKRiS was calculated at diagnosis, stratifying patients into low-, moderate-, high-, and very high-risk groups. The Fine-Gray model was used for the analysis of 36-month kidney failure, with the predictive performance assessed via Harrell C-index. Results The median AKRiS was 18 [11-21], with 69% of patients classified as high or very high-risk. The 36-month cumulative incidence of kidney failure was significantly higher in the high-risk (92% [95% confidence interval (CI), 82-97]) and very high-risk (98% [95% CI, 86-100]) groups, when compared with the low-risk (40% [95% CI, 19-61]; P P = 0.02). Despite higher AKRiS scores, double-positive patients had similar 36-month kidney failure compared with single-positive patients, reflecting their divergent pathophysiological and therapeutic responsiveness. Conclusion AKRiS is associated with renal risk in anti-GBM disease, irrespective of ANCA status. Its predictive performance further improves when combined with oligoanuria, supporting the development of pragmatic prognostic models for anti-GBM disease.